Average Insider

Where insiders trade, we follow

$ALMS
Alumis Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of medicines for autoimmune disorders. It develops ESK-001, an allosteric tyrosine kinase 2 (TYK2) inhibitor for the treatment of plaque psoriasis, systemic lupus erythematosus, and non-infectious uveitis; and A-005, a central nervous system-penetrant allosteric TYK2 inhibitor for neuroinflammatory and neurodegenerative diseases. The company was formerly known as Esker Therapeutics, Inc. and changed its name to Alumis Inc. in January 2022. The company was incorporated in 2021 and is headquartered in South San Francisco, California.
Healthcare
Sector
Biotechnology
Industry
Martin Babler
CEO
168
Employees
$6.55
Current Price
$2.87B
Market Cap
52W Low$4.40
Current$6.558.0% above low, 92.0% below high
52W High$31.35

Insider Activity Statistics

Aggregated buying and selling activity by time period
PeriodTypeInsidersTransactionsValueSharesBuy/Sell Ratio
1 weekBuys00---
Sells00--
2 weeksBuys00---
Sells00--
1 monthBuys00--All Sells
Sells66$23,621.963,623
2 monthsBuys00--All Sells
Sells66$23,621.963,623
3 monthsBuys14$10,726,255.17986,72110.34:1
Sells78$1,037,650.2099,754
See activity going back 12 months โ€” create a free account

Insider Transactions

Recent purchases and sales by company insiders
DateInsiderTypeSharesPriceValueActions
Nov 2, 2026
Schroer John R.
Chief Financial Officer
Sale794$6.52$5,176.88View Details
Nov 2, 2026
Pangali Sanam
Chief Legal Officer
Sale332$6.52$2,164.64View Details
Nov 2, 2026
Hardiman Roy C.
Chief Business&Strategy Ofcr
Sale652$6.52$4,251.04View Details
Nov 2, 2026
Goldstein David M
Chief Scientific Officer
Sale629$6.52$4,101.08View Details
Nov 2, 2026
Drappa Jorn
Chief Medical Officer
Sale593$6.52$3,866.36View Details
Nov 2, 2026
Bradley Mark Christopher
Chief Development Officer
Sale623$6.52$4,061.96View Details
Sep 8, 2026
AKKARAJU SRINIVAS
Director
Sale48,065$10.55$507,008.85View Details
Sep 8, 2026
AKKARAJU SRINIVAS
Director
Purchase273,290$10.63$2,904,280.16View Details
Sep 4, 2026
AKKARAJU SRINIVAS
Director
Purchase220,070$11.17$2,458,842.11View Details
Sep 8, 2026
AKKARAJU SRINIVAS
Director
Sale48,066$10.55$507,019.39View Details
Sep 8, 2026
AKKARAJU SRINIVAS
Director
Purchase273,291$10.63$2,904,290.79View Details
Sep 4, 2026
AKKARAJU SRINIVAS
Director
Purchase220,070$11.17$2,458,842.11View Details
35 more transactions available โ€” create a free account to see 12 months of history

Upcoming Earnings

Scheduled earnings reports
No upcoming earnings scheduled

Past Earnings

Historical earnings results
Nov 12, 2026
EPS
Estimated-$0.76
Actual-$0.73
Beat
Revenue
Estimated$1.90M
Actual$1.91M
Beat
3 more earnings records available โ€” create a free account to see 12 months of history

Related Activity

Cross-company insider connections and cluster buy signals
Version: v26.11.1